PubMed

Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ.

Diabetes Care. 2007 Apr;30(4):890-5. Epub 2007 Feb 2.PMID: 17277036 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.

Bolli G, Dotta F, Rochotte E, Cohen SE.

Diabetes Obes Metab. 2008 Jan;10(1):82-90. Epub 2007 Nov 22.PMID: 18034842 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.

Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S.

Diabetes Obes Metab. 2007 Mar;9(2):166-74.PMID: 17300592 [PubMed - indexed for MEDLINE]Related articles

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.

Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA.

Diabetes Obes Metab. 2008 Nov;10(11):1047-56. Epub 2008 Feb 18.PMID: 18284434 [PubMed - indexed for MEDLINE]Related articles

Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy.

Pratley RE, Rosenstock J, Pi-Sunyer FX, Banerji MA, Schweizer A, Couturier A, Dejager S.

Diabetes Care. 2007 Dec;30(12):3017-22. Epub 2007 Sep 18.PMID: 17878242 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin.

Göke B, Hershon K, Kerr D, Calle Pascual A, Schweizer A, Foley J, Shao Q, Dejager S.

Horm Metab Res. 2008 Dec;40(12):892-5. Epub 2008 Aug 22.PMID: 18726829 [PubMed - indexed for MEDLINE]Related articles

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Rosenstock J, Baron MA, Dejager S, Mills D, Schweizer A.

Diabetes Care. 2007 Feb;30(2):217-23. Erratum in: Diabetes Care. 2007 May;30(5):1330. PMID: 17259484 [PubMed - indexed for MEDLINE]Related articlesFree article

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.

Ferrannini E, Fonseca V, Zinman B, Matthews D, Ahrén B, Byiers S, Shao Q, Dejager S.

Diabetes Obes Metab. 2009 Feb;11(2):157-66.PMID: 19125777 [PubMed - indexed for MEDLINE]Related articles

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.

Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S.

Diabetologia. 2007 Jun;50(6):1148-55. Epub 2007 Mar 27.PMID: 17387446 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes.

Pi-Sunyer FX, Schweizer A, Mills D, Dejager S.

Diabetes Res Clin Pract. 2007 Apr;76(1):132-8. Epub 2007 Jan 12.PMID: 17223217 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.

Rosenstock J, Fitchet M.

Int J Clin Pract Suppl. 2008 Mar;(159):15-23. Review.PMID: 18269437 [PubMed - indexed for MEDLINE]Related articles

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes.

Ahrén B, Gomis R, Standl E, Mills D, Schweizer A.

Diabetes Care. 2004 Dec;27(12):2874-80.PMID: 15562200 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.

Scherbaum WA, Schweizer A, Mari A, Nilsson PM, Lalanne G, Jauffret S, Foley JE.

Diabetes Obes Metab. 2008 Aug;10(8):675-82. Epub 2007 Nov 22.PMID: 18248490 [PubMed - indexed for MEDLINE]Related articles

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.

Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S.

Diabetes Obes Metab. 2008 Sep;10(10):931-8. Epub 2007 Dec 17.PMID: 18093207 [PubMed - indexed for MEDLINE]Related articles

Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.

Ahrén B, Pacini G, Tura A, Foley JE, Schweizer A.

Horm Metab Res. 2007 Nov;39(11):826-9.PMID: 17992639 [PubMed - indexed for MEDLINE]Related articles

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.

Pan C, Yang W, Barona JP, Wang Y, Niggli M, Mohideen P, Wang Y, Foley JE.

Diabet Med. 2008 Apr;25(4):435-41. Epub 2008 Mar 13.PMID: 18341596 [PubMed - indexed for MEDLINE]Related articles

Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

Ahrén B, Pacini G, Foley JE, Schweizer A.

Diabetes Care. 2005 Aug;28(8):1936-40.PMID: 16043735 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia.

Scherbaum WA, Schweizer A, Mari A, Nilsson PM, Lalanne G, Wang Y, Dunning BE, Foley JE.

Diabetes Obes Metab. 2008 Nov;10(11):1114-24. Epub 2008 Mar 18.PMID: 18355325 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes.

Rosenstock J, Kim SW, Baron MA, Camisasca RP, Cressier F, Couturier A, Dejager S.

Diabetes Obes Metab. 2007 Mar;9(2):175-85.PMID: 17300593 [PubMed - indexed for MEDLINE]Related articles